Sapropterin Dihydrochloride

JAVYGTOR, Kuvan, ZELVYSIA

Phenylalanine Hydroxylase Activator

NADAC/unit N/A

No Shortage Tier 1: 66.0% PA Req: 335.3% 8 Manufacturers 17 ANDAs

Covered Lives

Market Intelligence

2024-12-18 Class III Recall: Dr. Reddy's Laboratories, Inc.

2024-05-15 Class I Recall: Dr. Reddy's Laboratories, Inc.

Generic Manufacturers

ANNORA PHARMA PRIVATE LTDAUCTA PHARMACEUTICALS INCAUROBINDO PHARMA LTDBIOMARIN PHARMACEUTICAL INCDR REDDYS LABORATORIES LTDMICRO LABS LTDPH HEALTH LTDTP ANDA HOLDINGS LLCZENARA PHARMA PRIVATE LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Sapropterin Dihydrochloride drfinder.aiFind doctors who prescribe Sapropterin Dihydrochloride rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Sapropterin Dihydrochloride

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.